Surface enhanced IR absorption of nucleic acids from tumor cells: FTIR reflectance study GI Dovbeshko, VI Chegel, NY Gridina, OP Repnytska, YM Shirshov, ... Biopolymers: Original Research on Biomolecules 67 (6), 470-486, 2002 | 242 | 2002 |
Multifactorial nature of tumor drug resistance GI Solyanik Exp Oncol 32 (3), 181-5, 2010 | 83 | 2010 |
Anticancer activity of aconitine-containing herbal extract BC1 GI Solyanik, AG Fedorchuk, ON Pyaskovskaya, OI Dasyukevitch, ... Exp Oncol 26 (4), 307-311, 2004 | 60 | 2004 |
A mathematical model of periodic processes in membranes (with application to cell cycle regulation) DS Chernavskii, EK Palamarchuk, AA Polezhaev, GI Solyanik, ... BioSystems 9 (4), 187-193, 1977 | 48 | 1977 |
Different growth patterns of a cancer cell population as a function of its starting growth characteristics: analysis by mathematical modelling GI Solyanik, NM Berezetskaya, RI Bulkiewicz, GI Kulik Cell proliferation 28 (5), 263-278, 1995 | 42 | 1995 |
Changes in VEGF level and tumor growth characteristics during Lewis lung carcinoma progression towards cis-DDP resistance ON Pyaskovskaya, OI Dasyukevich, DL Kolesnik, LV Garmanchouk, ... Experimental oncology, 2007 | 35 | 2007 |
Analysis of growth kinetics and proliferative heterogeneity of Lewis lung carcinoma cells growing as unfed culture ON Pyaskovskaya, DL Kolesnik, AV Kolobov, SI Vovyanko, GI Solyanik Experimental Oncology, 2008 | 34 | 2008 |
Quinazoline compounds for antitumor treatment GI Solyanik Experimental oncology 41 (1), 3-6, 2019 | 27 | 2019 |
Influence of aconitine-containing herbal extract BC1 on proliferative and electrokinetic characteristics of endothelial cells. LV Garmanchouk, ON Pyaskovskaya, YV Yanish, VA Shlyakhovenko, ... Experimental oncology 27 (4), 262-266, 2005 | 24 | 2005 |
Cisplatin-resistant Lewis lung carcinoma cells possess increased level of VEGF secretion GI Solyanik, ON Pyaskovskaya, LV Garmanchouk Экспериментальная онкология 25 (4), 260-265, 2003 | 23 | 2003 |
Comparative study of anticancer efficacy of aсonitinecontaining agent BC1 against ascite and solid forms of Ehrlich’s carcinoma OI Dasyukevich, GI Solyanik Experimental Oncology, 2007 | 22 | 2007 |
The role of cell motility in metastatic cell dominance phenomenon: analysis by a mathematical model AV Kolobov, AA Polezhaev, GI Solyanik Computational and Mathematical Methods in Medicine 3, 63-77, 2000 | 22 | 2000 |
Effectiveness of sodium dichloroacetate against glioma С6 depends on administration schedule and dosage AG Fedorchuk, ON Pyaskovskaya, GV Gorbik, IV Prokhorova, DL Kolesnik, ... Experimental oncology, 2016 | 20 | 2016 |
The SEIRA spectroscopy data of nucleic acids and phospholipids from sensitive-and drug-resistant rat tumours. VF Chekhun, GI Solyanik, GI Kulik, VP Tryndiak, IN Todor, GI Dovbeshko, ... Journal of Experimental & Clinical Cancer Research: CR 21 (4), 599-607, 2002 | 19 | 2002 |
2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma ON Pyaskovskaya, DL Kolesnik, AG Fedorchuk, IV Prochorova, ... Experimental Oncology, 2016 | 17 | 2016 |
The evaluation of prooxidant and antioxidant state of two variants of lewis lung carcinoma: a comparative study LV Sorokina, GI Solyanik, TV Pyatchanina Experimental Oncology, 2010 | 16 | 2010 |
Paraneoplastic syndrome in mice bearing high-angiogenic variant of Lewis lung carcinoma: relations with tumor derived VEGF OG Fedorchuk, OM Pyaskovskaya, LM Skivka, GV Gorbik, OO Trompak, ... Cytokine 57 (1), 81-88, 2012 | 15 | 2012 |
Relation of the intensity of metabolism with the process of determination in embryonic cell: Comparison of the Experimental Data with Theory DS Chernavskii, GI Solyanik, LV Belousov Biological Cybernetics 37 (1), 9-18, 1980 | 15 | 1980 |
Resistance of Guerin's carcinoma cells to cisplatine: Biochemical and morphological aspects OV Yurchenko, IN Todor, VP Tryndyak, NA Tregubova, OV Kovtonyuk, ... Экспериментальная онкология 25 (1), 64-68, 2003 | 14 | 2003 |
Metformin enhances antitumor action of sodium dichloroacetate against glioma C6 DL Kolesnik, ON Pyaskovskaya, OV Yurchenko, GI Solyanik Experimental Oncology 41 (2), 123-129, 2019 | 13 | 2019 |